A $190M insider affiliate proposed sale is unusually large relative to recent insider activity. Monitor for actual execution on Form 4, if completed, the increased float could pressure the stock near-term. Given Kymera's $9.6B market cap and 93% bullish analyst consensus, assess whether this is a liquidity-driven diversification by the fund or a signal of reduced conviction before the next catalyst (e.g., pipeline readout).
How the stock moved after the report
⚠ Clustered BEARISH VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 29 $109.32entry
- T+1 · 5mo ago +4.89%α +4.12% · $114.67
- T+5 · 4mo ago +4.98%α +3.59% · $114.76
- T+20 · 4mo ago +1.14%α +1.42% · $110.57
- T+60 · 8w ago +11.65%α +7.27% · $122.06
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
BVF Partners L.P./IL, an affiliate of a Kymera Therapeutics director, filed a Form 144 on June 26, 2026, signaling intent to sell 1,630,658 shares of common stock. At a market value of approximately $189.9 million (based on a $116.47 share price from market cap data), this represents about 1.98% of Kymera's $9.6B market cap and is a large, material insider-level sale by a major institutional holder.
Key Facts
- Reporting owner BVF Partners L.P./IL is an affiliate of a Kymera director
- Proposed sale of 1,630,658 shares of common stock
- Aggregate market value of approximately $189,906,430.68
- Shares were originally acquired on March 11, 2020, and converted to common stock in the IPO on August 21, 2020
- Sale to be conducted through Jefferies LLC on Nasdaq, dated June 26, 2026
- Only 3 insider sells totaling $5.8M were reported in the prior 30 days; this filing dwarfs that activity
Financial Impact
Proposed sale of ~1.98% of outstanding shares valued at ~$189.9 million (calculated from 1,630,658 shares × $116.47 estimated price based on $9.6B market cap / 82,257,588 shares outstanding per filing)
Risk Factors
- Potential near-term selling pressure if the entire block is executed quickly
- Insider sale by a director-affiliated fund may be perceived as lack of confidence
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0000921895-26-001685 |
| Document: 0000921895-26-001685-index.html | 0000921895-26-001685 |
| Document: 0000921895-26-001685.txt | 0000921895-26-001685 |
Track record
37 reports on KYMR
7 of 11 bullish or bearish reports moved the stock their way by T+20. Best: +60.99% at T+60 after the Jun 8, 2026 report. 9 of 13 went positive at some point.
Filters
- Nov 2, 202614d ago Institutional Cluster Neutral 3/10 Entry $127.09 Now $125.85 −0.98% settles Dec 2
- Oct 29, 202618d ago 8-K Neutral 5/10 No price data
- Oct 29, 202618d ago Press Release Bearish 5/10 Entry $122.60 Now $125.85 −2.65% settles Nov 27
- Oct 28, 202619d ago Press Release Neutral 5/10 Entry $122.60 Now $125.85 +2.65% settles Nov 27
- Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $122.51 Now $125.85 +2.73% settles Nov 25
- Oct 22, 202625d ago Press Release Neutral 1/10 Entry $110.85 Now $125.85 +13.53% settles Nov 20
- Aug 5, 202614w ago 8-K Bullish 6/10 Entry $105.48 to $118.63 Now $125.85 +19.31% ▲ +12.47% +13.07% vs SPY
- Jul 7, 202618w ago Insider Cluster Bearish 5/10 Entry $114.16 to $105.48 Now $125.85 −10.24% ▲ +7.60% +10.88% vs SPY
- Jul 2, 202619w ago Insider Cluster Bearish 5/10 Entry $114.76 to $100.31 Now $125.85 −9.66% ▲ +12.59% +13.44% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers